ONXEO Trademark

Trademark Overview

On Thursday, May 22, 2014, a trademark application was filed for ONXEO with the United States Patent and Trademark Office. The USPTO has given the ONXEO trademark a serial number of 86288671. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 30, 2021. This trademark is owned by BIOALLIANCE PHARMA. The ONXEO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

product research, namely, research services for conceiving and developing innovative products in the field of oncology
onxeo

General Information

Serial Number86288671
Word MarkONXEO
Filing DateThursday, May 22, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 30, 2021
Registration Number4815827
Registration DateTuesday, September 22, 2015
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 10, 2015

Trademark Statements

Description of MarkThe mark consists of the word "ONXeo", with the "O" and "N" in blue uppercase, the letters "e" and "o" in blue lowercase, and the letter "X" comprised of four legs in red, green, blue, and yellow and a black circle at the intersection of those legs.
Indication of Colors claimedThe color(s) blue, black, red, green and yellow is/are claimed as a feature of the mark.
Goods and Servicesproduct research, namely, research services for conceiving and developing innovative products in the field of oncology

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, June 5, 2014
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVALERIO THERAPEUTICS S.A.
Party Type32 - New Owner After Registration
Legal Entity Type33 - NOT AVAILABLE
AddressPARIS 75015
FR
Party NameONXEO
Party Type31 - New Owner After Registration
Legal Entity Type99 - Other
AddressParis 75015
FR
Party NameBIOALLIANCE PHARMA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressParis 75015
FR
Party NameBIOALLIANCE PHARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressParis 75015
FR
Party NameBIOALLIANCE PHARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressParis 75015
FR

Trademark Events

Event DateEvent Description
Monday, May 26, 2014NEW APPLICATION ENTERED
Thursday, June 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 6, 2014NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 5, 2014ASSIGNED TO EXAMINER
Saturday, September 6, 2014NON-FINAL ACTION WRITTEN
Saturday, September 6, 2014NON-FINAL ACTION E-MAILED
Saturday, September 6, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 16, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 29, 2015ASSIGNED TO LIE
Thursday, January 29, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 29, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 4, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 10, 2015PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, May 13, 2015TEAS DELETE 1(B) BASIS RECEIVED
Wednesday, May 13, 2015NOTICE OF ALLOWANCE CANCELLED
Thursday, June 4, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, June 4, 20151(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, September 22, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, September 22, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, February 17, 2021TEAS SECTION 8 & 15 RECEIVED
Sunday, June 27, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 30, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 30, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Monday, July 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, July 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, July 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 24, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 26, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sunday, September 22, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

onxeo research products field oncology innovative conceiving namely services product developing